Development and Provision of
Innovative Healthcare Products
PT Sigma Bioscience Indonesia focuses on the identification, development, and provision of healthcare products that offer clinical added value and are relevant to the needs of the national healthcare system.
The product scope includes: medical devices, pharmaceuticals, bioscience products, and technology-based healthcare solutions.
In every product selection and development process, we apply comprehensive evaluation covering regulatory aspects, safety, effectiveness, supply sustainability, and long-term market growth potential.
Development and Provision of
Innovative Healthcare Products
PT Sigma Bioscience Indonesia focuses on the identification, development, and provision of healthcare products that offer clinical added value and are relevant to the needs of the national healthcare system.
The product scope includes: medical devices, pharmaceuticals, bioscience products, and technology-based healthcare solutions.
In every product selection and development process, we apply comprehensive evaluation covering regulatory aspects, safety, effectiveness, supply sustainability, and long-term market growth potential.
Innovative Wound Care
Portfolio Development
As part of the company’s current strategic focus, PT Sigma Bioscience Indonesia is developing a wound care portfolio designed to address clinical challenges in wound management, both at primary healthcare facilities and referral hospitals.
Our wound care portfolio includes:
- Next-generation antiseptics and antimicrobials with proven effectiveness
- Solutions for infection prevention and control in wound care
- Products that support optimal and controlled wound healing processes
Innovative Wound Care
Portfolio Development
As part of the company’s current strategic focus, PT Sigma Bioscience Indonesia is developing a wound care portfolio designed to address clinical challenges in wound management, both at primary healthcare facilities and referral hospitals.
Our wound care portfolio includes:
- Next-generation antiseptics and antimicrobials with proven effectiveness
- Solutions for infection prevention and control in wound care
- Products that support optimal and controlled wound healing processes
Strategic Market Expansion
and Commercialization
Services
PT Sigma Bioscience Indonesia is a strategic partner for global and regional companies seeking to enter and expand in the Indonesian market in a structured and compliant manner.
We provide end-to-end services, including market research, market entry strategy, regulatory registration and licensing (BPOM, Ministry of Health, TKDN), import facilitation or local production, national distribution management, medical education for healthcare professionals, as well as branding and market penetration strategies.
With an integrated approach, we ensure our partners are fully prepared across regulatory, operational, distribution, and market development aspects.
Strategic Market Expansion
and Commercialization
Services
PT Sigma Bioscience Indonesia is a strategic partner for global and regional companies seeking to enter and expand in the Indonesian market in a structured and compliant manner.
We provide end-to-end services, including market research, market entry strategy, regulatory registration and licensing (BPOM, Ministry of Health, TKDN), import facilitation or local production, national distribution management, medical education for healthcare professionals, as well as branding and market penetration strategies.
With an integrated approach, we ensure our partners are fully prepared across regulatory, operational, distribution, and market development aspects.